| Title |
Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
|
|---|---|
| Published in |
PLOS ONE, April 2008
|
| DOI | 10.1371/journal.pone.0001927 |
| Pubmed ID | |
| Authors |
Lisa G. M. van Baarsen, Saskia Vosslamber, Marianne Tijssen, Josefien M. C. Baggen, Laura F. van der Voort, Joep Killestein, Tineke C. T. M. van der Pouw Kraan, Chris H. Polman, Cornelis L. Verweij |
| Abstract |
Multiple sclerosis (MS) is a heterogeneous disease. In order to understand the partial responsiveness to IFNbeta in Relapsing Remitting MS (RRMS) we studied the pharmacological effects of IFNbeta therapy. |
Mendeley readers
The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 3% |
| Brazil | 1 | 1% |
| Netherlands | 1 | 1% |
| Mexico | 1 | 1% |
| Spain | 1 | 1% |
| Unknown | 66 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 29% |
| Student > Ph. D. Student | 14 | 19% |
| Other | 6 | 8% |
| Professor > Associate Professor | 6 | 8% |
| Student > Bachelor | 5 | 7% |
| Other | 14 | 19% |
| Unknown | 6 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 24 | 33% |
| Medicine and Dentistry | 22 | 31% |
| Neuroscience | 6 | 8% |
| Immunology and Microbiology | 4 | 6% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Other | 7 | 10% |
| Unknown | 6 | 8% |